We are live on ! Find out more
Cambridge Investment Research Advisors

Cambridge Investment Research Advisors Portfolio holdings

AUM $44.6B
1-Year Est. Return 28.94%
This Fund
S&P 500
This Quarter Est. Return
-13.27%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$18.6B
AUM Growth
-$3.22B
Cap. Flow
-$14.7M
Cap. Flow %
-0.08%
Top 10 Hldgs %
18.18%
Holding
3,301
New
145
Increased
1,425
Reduced
1,371
Closed
260

Sector Composition

Rank Sector Weight
1 Technology 9.03%
2 Financials 4.72%
3 Healthcare 4.25%
4 Consumer Discretionary 4.16%
5 Industrials 2.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QSI icon
2926
Quantum-Si Incorporated
QSI
$172M
$59K ﹤0.01%
25,217
+260
+1% +$996
CIK
2927
Credit Suisse Asset Management Income Fund
CIK
$134M
$57K ﹤0.01%
21,000
FUBO icon
2928
FuboTV Inc
FUBO
$296M
$57K ﹤0.01%
1,936
-746
-28% -$34.8K
XPL icon
2929
Solitario Resources
XPL
$73.9M
$57K ﹤0.01%
99,761
DRRX
2930
DELISTED
DURECT Corp
DRRX
$56K ﹤0.01%
11,809
-621
-5% -$2.97K
SNDL icon
2931
Sundial Growers
SNDL
$311M
$56K ﹤0.01%
17,046
+80
+0.5% +$354
ASX icon
2932
ASE Group
ASX
$103B
$55K ﹤0.01%
+10,716
New +$71.4K
SFIX
2933
Stitch Fix
SFIX
$487M
$54K ﹤0.01%
11,021
-4,894
-31% -$40.9K
RJET
2934
Republic Airways Holdings
RJET
$964M
$53K ﹤0.01%
1,599
+99
+7% +$4.65K
TONX
2935
TON Strategy Co
TONX
$160M
$53K ﹤0.01%
13
AGEN
2936
Agenus
AGEN
$315M
$52K ﹤0.01%
1,376
HRTX icon
2937
Heron Therapeutics
HRTX
$63.5M
$51K ﹤0.01%
18,317
-1,500
-8% -$6.02K
ORMP icon
2938
Oramed Pharmaceuticals
ORMP
$182M
$51K ﹤0.01%
+11,184
New +$59.8K
CTXR icon
2939
Citius Pharmaceuticals
CTXR
$20.1M
$50K ﹤0.01%
2,184
-11
-0.5% -$302
VVR icon
2940
Invesco Senior Income Trust
VVR
$459M
$50K ﹤0.01%
12,761
+845
+7% +$3.4K
BTG icon
2941
B2Gold
BTG
$6.7B
$48K ﹤0.01%
14,204
-1,112
-7% -$4.64K
NXE icon
2942
NexGen Energy
NXE
$6.97B
$48K ﹤0.01%
13,266
-13,274
-50% -$63K
ASRT
2943
DELISTED
Assertio
ASRT
$46K ﹤0.01%
1,049
+100
+11% +$4.17K
PSFE icon
2944
Paysafe
PSFE
$405M
$45K ﹤0.01%
1,916
-473
-20% -$15.3K
APPH
2945
DELISTED
AppHarvest, Inc. Common Stock
APPH
$44K ﹤0.01%
12,748
-13,969
-52% -$50.1K
BFLY icon
2946
Butterfly Network
BFLY
$2.36B
$43K ﹤0.01%
+14,034
New +$48.5K
PHX
2947
DELISTED
PHX Minerals
PHX
$43K ﹤0.01%
14,053
+3,196
+29% +$11.2K
SOLO
2948
DELISTED
Electrameccanica Vehicles Corp. Ltd.
SOLO
$43K ﹤0.01%
31,691
-50
-0.2% -$83
AMRS
2949
DELISTED
Amyris Inc.
AMRS
$43K ﹤0.01%
23,020
+700
+3% +$2.06K
FTCI icon
2950
FTC Solar
FTCI
$40.1M
$42K ﹤0.01%
1,172
+110
+10% +$4.36K

Similar funds

Cambridge Investment Research Advisors's Q2 2022 Portfolio in Review

As of Q2 2022, Cambridge Investment Research Advisors held 3,301 positions worth $18.6B, down 15% from $21.8B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Cambridge Investment Research Advisors's Q2 2022 filing shows 145 new, 1,425 increased, 1,371 reduced and 260 closed positions. Its largest new stake was Simplify US Equity PLUS Downside Convexity ETF: 863,983 shares worth $22.9M. The largest sale was Invesco QQQ Trust, an estimated $84.3M.

By sector, the portfolio is most concentrated in Technology at 9% of assets, down from 9.9% a quarter earlier, followed by Financials and Healthcare.

  • Cambridge Investment Research Advisors's largest Q2 2022 buy was Simplify US Equity PLUS Downside Convexity ETF: 863,983 shares worth $22.9M.
  • Cambridge Investment Research Advisors added most to State Street SPDR Bloomberg 1-3 Month T-Bill ETF in Q2 2022, an estimated $82M increase.
  • Cambridge Investment Research Advisors's biggest Q2 2022 reduction was Invesco QQQ Trust, cutting an estimated $84.3M.
  • Cambridge Investment Research Advisors fully exited State Street SPDR Bloomberg International Treasury Bond ETF in Q2 2022, selling an estimated $18M.
  • Cambridge Investment Research Advisors's ten largest holdings make up 18% of its $18.6B portfolio in Q2 2022.
  • Cambridge Investment Research Advisors opened 145 new positions and closed 260 in Q2 2022.
  • Cambridge Investment Research Advisors's portfolio value fell 15% quarter-over-quarter to $18.6B.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2022, filed 13 Jul 2022.